BioPulse

Clinical Trial · NCT07214727

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

← 임상시험ClinicalTrials.gov ↗
1상모집 중

Study Summary

The purpose of this study is to: * Evaluate the safety and tolerability of intrathecal (IT) ALN-5288 in patients with Alzheimer's Disease (AD) * Evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) effects of ALN-5288 after dose administration

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease (NCT07214727) | BioPulse